| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A L Ells, G A Gole, P Lloyd Hildebrand, A Ingram, C M Wilson, R Geoff William. Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity. Eye (London, England). vol 27. issue 4. 2013-09-10. PMID:23328804. |
current methods of treating the avascular retina with laser photocoagulation for severe retinopathy of prematurity (rop) are not completely effective in the reduction of visual morbidity. |
2013-09-10 |
2023-08-12 |
Not clear |
| A L Ells, G A Gole, P Lloyd Hildebrand, A Ingram, C M Wilson, R Geoff William. Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity. Eye (London, England). vol 27. issue 4. 2013-09-10. PMID:23328804. |
we report a case series in which additional laser treatment, called 'posterior laser', was delivered posterior to the neovascular ridge, for eyes with severe stage 3 rop in zone ii with avascular retina posterior to the ridge. |
2013-09-10 |
2023-08-12 |
Not clear |
| Rui-Hong Ju, Jia-Qing Zhang, Xiao-Yun Ke, Xiao-He Lu, Li-Fang Liang, Wu-Jun Wan. Spontaneous regression of retinopathy of prematurity: incidence and predictive factors. International journal of ophthalmology. vol 6. issue 4. 2013-08-30. PMID:23991382. |
to evaluate the incidence of spontaneous regression of changes in the retina and vitreous in active stage of retinopathy of prematurity(rop) and identify the possible relative factors during the regression. |
2013-08-30 |
2023-08-12 |
Not clear |
| V V Neroev, L V Kogoleva, L A Katargin. [Clinical course and results of treatment of zone I retinopathy of prematurity]. Vestnik oftalmologii. vol 129. issue 3. 2013-08-13. PMID:23879018. |
coagulation of retina in active i zone rop showed efficacy in 70%: in posterior rop - 56,3%, in anterior rop - 79%. |
2013-08-13 |
2023-08-12 |
Not clear |
| V V Neroev, L V Kogoleva, L A Katargin. [Clinical course and results of treatment of zone I retinopathy of prematurity]. Vestnik oftalmologii. vol 129. issue 3. 2013-08-13. PMID:23879018. |
lens-sparing vitrectomy at gestational age of 44-45 weeks resulted in partial or total reattachment of retina that was achieved in 5 eyes with 4a-4b stage rop. |
2013-08-13 |
2023-08-12 |
Not clear |
| Manabu McCloskey, Haibo Wang, Yanchao Jiang, George Wesley Smith, Jeremy Strange, M Elizabeth Hartnet. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Investigative ophthalmology & visual science. vol 54. issue 3. 2013-05-21. PMID:23449716. |
inhibiting vegf improves adult retino/choroido-vascular diseases, but can lead to recurrent intravitreous neovascularization (ivnv), avascular retina (ava), and retinal detachment in preterm infants with retinopathy of prematurity (rop). |
2013-05-21 |
2023-08-12 |
rat |
| Fatih Mehmet Mutlu, Serdar Umit Saric. Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. International journal of ophthalmology. vol 6. issue 2. 2013-05-06. PMID:23641347. |
although ablation of the avascular retina with laser photocoagulation remains the current gold standard and well established therapy for rop, some new therapeutic options including angiostatic therapies are being explored based on our knowledge of the pathophysiology of the rop and complications and efficacy of laser treatment. |
2013-05-06 |
2023-08-12 |
Not clear |
| Lidia Puchalska-Niedbał, Monika Modrzejewska, Urszula Kuli. Rapid onset anterior segment complication following diode laser photocoagulation for retinopathy of prematurity: a case report. Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques. vol 8. issue 1. 2013-05-01. PMID:23630561. |
confluent, laser ablation of avascular retina (iris medical, oculight s) in order to prevent the progression of rop was applied. |
2013-05-01 |
2023-08-12 |
Not clear |
| Carlo Dani, Saverio Frosini, Pina Fortunato, Giovanna Bertini, Simone Pratesi, Liliana Pollazzi, Roberto Caputo, Agostino La Torr. Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. vol 25. issue 11. 2013-04-30. PMID:22506618. |
laser therapy is effective in the treatment of severe forms of retinopathy of prematurity (rop), and aggressive posterior rop (aprop), but always damages the retina. |
2013-04-30 |
2023-08-12 |
Not clear |
| Wojciech Podraza, Hanna Podraza, Karolina Jezierska, Joanna Szwed, Hanna Domek, Agnieszka Kordek, Monika Modrzejewska, Jacek Rudnick. EEG, brain maturation, and the development of retinopathy of prematurity. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. vol 25. issue 11. 2013-04-30. PMID:22630132. |
the immature retina is more vulnerable than the mature retina, and is therefore more likely to develop retinopathy of prematurity (rop). |
2013-04-30 |
2023-08-12 |
Not clear |
| Helen A Mintz-Hittne. Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors. Early human development. vol 88. issue 12. 2013-04-11. PMID:23078830. |
with an understanding of rop pathogenesis, vascular endothelial growth factor inhibitors (anti-vegf) are being given only when vegf is elevated in retina and vitreous. |
2013-04-11 |
2023-08-12 |
Not clear |
| Sih Min Tan, Nada Stefanovic, Genevieve Tan, Jennifer L Wilkinson-Berka, Judy B de Haa. Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice. Investigative ophthalmology & visual science. vol 54. issue 1. 2013-03-19. PMID:23287791. |
we postulated that gpx1 plays an important role in protecting the premature retina from oxidative injury in a mouse model of rop. |
2013-03-19 |
2023-08-12 |
mouse |
| Ingele Casteels, Catherine Cassiman, Joachim Van Calster, Karel Allegaer. Educational paper: Retinopathy of prematurity. European journal of pediatrics. vol 171. issue 6. 2012-10-17. PMID:22052209. |
retinopathy of prematurity (rop) is a proliferative retinal vascular disease affecting the premature infant with an incompletely vascularized retina. |
2012-10-17 |
2023-08-12 |
Not clear |
| Ryan K Wong, Camila V Ventura, Michael J Espiritu, Yoshihiro Yonekawa, Laure Henchoz, Michael F Chiang, Thomas C Lee, Robison V Paul Cha. Training fellows for retinopathy of prematurity care: a Web-based survey. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. vol 16. issue 2. 2012-06-29. PMID:22525176. |
to characterize the training received by pediatric ophthalmology and retina fellows in retinopathy of prematurity (rop) management. |
2012-06-29 |
2023-08-12 |
Not clear |
| Jennifer Lee, Olaf Damman. Perinatal infection, inflammation, and retinopathy of prematurity. Seminars in fetal & neonatal medicine. vol 17. issue 1. 2012-05-09. PMID:21903492. |
taken together, accumulating evidence suggests that prenatal, perinatal, and postnatal systemic inflammation contribute to a 'pre-phase', sensitizing the pre-rop retina for subsequent insults, setting the stage for what are now called phase i and phase ii of rop pathogenesis. |
2012-05-09 |
2023-08-12 |
Not clear |
| José Carlos Rivera, Przemyslaw Sapieha, Jean-Sébastien Joyal, François Duhamel, Zhuo Shao, Nicholas Sitaras, Emilie Picard, Ellen Zhou, Pierre Lachapelle, Sylvain Chemto. Understanding retinopathy of prematurity: update on pathogenesis. Neonatology. vol 100. issue 4. 2012-03-15. PMID:21968165. |
retinopathy of prematurity (rop), an ocular disease characterized by the onset of vascular abnormalities in the developing retina, is the major cause of visual impairment and blindness in premature neonates. |
2012-03-15 |
2023-08-12 |
Not clear |
| José Carlos Rivera, Przemyslaw Sapieha, Jean-Sébastien Joyal, François Duhamel, Zhuo Shao, Nicholas Sitaras, Emilie Picard, Ellen Zhou, Pierre Lachapelle, Sylvain Chemto. Understanding retinopathy of prematurity: update on pathogenesis. Neonatology. vol 100. issue 4. 2012-03-15. PMID:21968165. |
this review summarizes an update on the current state of knowledge on rop from our and other laboratories, with particular focus on the role of nitro-oxidative stress and notably trans-arachidonic acids in microvascular degeneration, semaphorin 3 operating as vasorepulsive molecules in the avascular hypoxic retina and in turn impairing revascularization, succinate and its receptor gpr91 in neuron-mediated retinal neovascularization, and ω-3 lipids as modulators of preretinal neovascularization. |
2012-03-15 |
2023-08-12 |
Not clear |
| E Kermorvant-Duchemin, F Sennlaub, F Behar-Cohen, S Chemto. [Epidemiology and pathophysiology of retinopathy of prematurity]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. vol 18 Suppl 2. 2011-12-06. PMID:21763979. |
the proliferative, second phase of rop is triggered by increases in vascular growth factors concentrations, in an attempt to compensate for the hypoxic retina. |
2011-12-06 |
2023-08-12 |
Not clear |
| Maureen E Harris, Anne Moskowitz, Anne B Fulton, Ronald M Hanse. Long-term effects of retinopathy of prematurity (ROP) on rod and rod-driven function. Documenta ophthalmologica. Advances in ophthalmology. vol 122. issue 1. 2011-06-02. PMID:21046193. |
the data are evidence that sensitivity of the post-receptor retina improves in those with a history of mild rop. |
2011-06-02 |
2023-08-12 |
human |
| Mary Elizabeth Hartnet. Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis). Transactions of the American Ophthalmological Society. vol 108. 2011-05-19. PMID:21212851. |
to study vascular endothelial growth factor (vegf) regulation in the development of intravitreous neovascularization and peripheral avascular retina in peripheral severe retinopathy of prematurity (rop). |
2011-05-19 |
2023-08-12 |
Not clear |